You just read:

U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa® for Third Year

News provided by

Portola Pharmaceuticals, Inc.®

May 14, 2020, 08:00 ET